Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
Public ClinicalTrials.gov record NCT00096460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Autologous Versus Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response (BMT CTN #0202)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed as a Phase II/III, multi-center trial, comparing two transplant strategies to determine whether non-myeloablative allogeneic Hematopoietic Stem Cell Transplantation (HSCT) will improve long-term progression-free survival compared to autologous HSCT. Recipients will be biologically assigned to the appropriate treatment arm depending on the availability of a Human Leukocyte Antigen (HLA) matched sibling.
Study identification
- NCT ID
- NCT00096460
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- Cyclophosphamide and Rituximab Drug
- Filgrastim Drug
- Chemotherapy or Radiation therapy Radiation
- Non-myeloablative Conditioning regimen Drug
- Allogeneic transplant Procedure
- Autologous transplant Procedure
- Rituximab maintenance therapy Drug
- GVHD Prophylaxis Drug
Drug · Radiation · Procedure
Eligibility (public fields only)
- Age range
- Up to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2004 (Type not available)
- Primary completion
- Mar 2006 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- Jan 5, 2023
2004 – 2009
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010-3000 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| UCSD Medical Center | La Jolla | California | 92093 | — |
| Stanford Hospital and Clinics | Stanford | California | 94305 | — |
| University of Florida College of Medicine (Shands) | Gainesville | Florida | 32610-0277 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33624 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| BMT Group of Georgia | Atlanta | Georgia | 30342 | — |
| Loyola University | Atlanta | Georgia | 60153 | — |
| Indiana BMT at Beech Grove | Beech Grove | Indiana | 46107 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48105-2967 | — |
| Karmanos Cancer Institute/BMT | Detroit | Michigan | 48201 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Kansas City Cancer Centers | Kansas City | Missouri | 64111 | — |
| Washington University/Barnes Jewish Hospital | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-7680 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| University Hospitals of Cleveland/Case Western | Cleveland | Ohio | 44106-5061 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239-3098 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Cancer Institute | Pittsburgh | Pennsylvania | 15232 | — |
| Vanderbilt University | Nashville | Tennessee | 37232-8210 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| University of Texas/MD Anderson CRC | Houston | Texas | 77030 | — |
| Virginia Commonwealth University MCV Hospitals | Richmond | Virginia | 23298 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792-5156 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53211 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00096460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 5, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00096460 live on ClinicalTrials.gov.